Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 2,609 | 1,921 | 5,009 | 1,857 | 1,143 |
| Gross Profit | 2,609 | 1,921 | 5,009 | 1,857 | 1,143 |
| Operating Expenses | 1,324 | 1,469 | 1,689 | 1,722 | 1,467 |
| Operating Income | 1,284 | 452 | 3,320 | 135 | -323 |
| Other Income | 16 | 8 | 31 | 17 | 457 |
| Pre-tax Income | 1,300 | 460 | 3,351 | 152 | 134 |
| Income Tax | 1,229 | 190 | 782 | -3,539 | -7 |
| Net Income Continuous | 71 | 270 | 2,569 | 3,691 | 140 |
| Net Income | $71 | $270 | $2,569 | $3,691 | $140 |
| EPS Basic Total Ops | 0.01 | 0.04 | 0.40 | 0.59 | 0.03 |
| EPS Basic Continuous Ops | 0.01 | 0.04 | 0.40 | 0.59 | 0.02 |
| EPS Diluted Total Ops | 0.04 | 0.04 | 0.36 | 0.51 | 0.03 |
| EPS Diluted Continuous Ops | 0.04 | 0.04 | 0.36 | 0.51 | 0.02 |
| EBITDA(a) | $1,303 | $463 | $3,331 | $146 | $-314 |